Burkitt t(8;14)(q24;q32) and cryptic deletion in a CLL patient: report of a case and review of literature

Cancer Genetics and Cytogenetics

Volumn 166, Issue 1, 2006, Pages 12-21

  Reddy, Kavita ^a   Satyadev, Radha ^a   Bouman, Derek ^a   Hibbard, Michele K ^a   Lu, Gary ^a   Paolo, Romero ^b  

^a US Labs   (United States)

^b Heart Center of the Rockies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD19 ANTIGEN; CD20 ANTIBODY; CD22 ANTIGEN; CD23 ANTIGEN; CD38 ANTIGEN; CD5 ANTIGEN;

ADULT; ARTICLE; B LYMPHOCYTE; BONE MARROW; BURKITT LYMPHOMA; CASE REPORT; CELL VIABILITY; CHROMOSOME 8; CHRONIC LYMPHATIC LEUKEMIA; COMPARATIVE STUDY; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE FUSION; GENE TRANSLOCATION; HUMAN; KARYOTYPE; KARYOTYPE 46,XY; LYMPHOCYTE; LYMPHOID CELL; MALE; MEDICAL LITERATURE; METAPHASE; ONCOGENE MYC; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMEAR; SPLEEN; SPLENECTOMY;

BURKITT LYMPHOMA; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 8; GENES, MYC; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MIDDLE AGED; SPLENECTOMY; TRANSLOCATION, GENETIC;

EID: 33645971982     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.08.025     Document Type: Article

References (34)

1. DiGiuseppe J.A., and Borowitz M.J. Clinical utility of flow cytometry in the chronic lymphoid leukemias. Semin Oncol 25 (1998) 6-10
2. Oscier D.G., Gardiner A.C., Mould S.J., Glide S., Davis Z.A., Ibbotson R.E., Corcoran M.M., Chapman R.M., Thomas P.W., Copplestone J.A., Orchard J.A., and Hamblin T.J. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 100 (2002) 1177-1184
3. Juliusson G., Oscier D.G., Fitchett M., Ross F.M., Stockdill G., Mackie M.J., Parker A.C., Castoldi G.L., Guneo A., Knuutila S., et al. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 323 (1990) 720-724
4. Dohner H., Stilgenbauer S., Benner A., Leupolt E., Krober A., Bullinger L., Dohner K., Bentz M., and Lichter P. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343 (2000) 1910-1916
5. Dewald G.W., Brockman S.R., Paternoster S.F., Bone N.D., O'Fallon J.R., Allmer C., James C.D., Jelinek D.F., Tschumper R.C., Hanson C.A., Pruthi R.K., Witzig T.E., Call T.G., and Kay N.E. Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia. Br J Haematol 121 (2003) 287-295
6. Stilgenbauer S., and Dohner H. Molecular genetics and its clinical relevance. Hematol Oncol Clin North Am 18 (2004) 827-848 viii
7. Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer [Internet]. Updated February 2005. Available from http://cgap.nci.nih.gov/Chromosomes/Mitelman
8. Dohner H., Stilgenbauer S., Dohner K., Bentz M., and Lichter P. Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J Mol Med 77 (1999) 266-281
9. Fleischman E.W., and Prigogina E.L. Karyotype peculiarities of malignant lymphomas. Hum Genet 35 (1977) 269-279
10. Levine E.G., Arthur D.C., Frizzera G., Peterson B.A., Hurd D.D., and Bloomfield C.D. There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin lymphomas. Blood 66 (1985) 1414-1422
11. Juliusson G., Friberg K., and Gahrton G. Consistency of chromosomal aberrations in chronic B-lymphocytic leukemia: a longitudinal cytogenetic study of 41 patients. Cancer 62 (1988) 500-506
12. Palka G., Fioritoni G., Lombardo M., Donti E., Calabrese G., Stuppia L., Di Marco G., Guanciali Franchi P., Parruti G., and Geraci L. Chromosome abnormalities in PHA-stimulated and non stimulated bone marrow cultures from patients with non Hodgkin lymphoma. Haematologica 73 (1988) 489-494
13. Asou N., Osato M., Horikawa K., Nishikawa K., Sakitani O., Li L., Yamasaki H., Nishimura S., Okubo T., Suzushima H., and Takatsuki K. Burkitt's type acute lymphoblastic transformation associated with t(8;14) in a case of B cell chronic lymphocytic leukemia. Leukemia 11 (1997) 1986-1988
14. Mark H.F., Sotomayor E., and Mega A. Occurrence of both t(1;19) and t(8;14) in a patient with chronic lymphocytic leukemia. Exp Mol Pathol 66 (1999) 238-242
15. Xue Y., Yu F., Zhou Z., He Z., Guo Y., Wang M., and Lin B. Complex karyotypic abnormalities including t(8;22) in a patient with chronic lymphocytic leukemia. Cancer Genet Cytogenet 65 (1993) 157-160
16. Sole F., Woessner S., Perez-Losada A., Florensa L., Montero S., Asensio A., Besses C., and Sans-Sabrafen J. Cytogenetic studies in seventy-six cases of B-chronic lymphoproliferative disorders. Cancer Genet Cytogenet 93 (1997) 160-166
17. Hamblin T.J., Davis Z., Gardiner A., Oscier D.G., and Stevenson F.K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94 (1999) 1848-1854
18. Mohamed A.N., Compean R., Dan M.E., Smith M.R., and Al-Katib A. Clonal evolution of chronic lymphocytic leukemia to acute lymphoblastic leukemia. Cancer Genet Cytogenet 86 (1996) 143-146
19. Litz C.E., Arthur D.C., Gajl-Peczalska K.J., Rausch D., Copenhaver C., Coad J.E., and Brunning R.D. Transformation of chronic lymphocytic leukemia to small non-cleaved cell lymphoma: a cytogenetic, immunological, and molecular study. Leukemia 5 (1991) 972-978
20. Hsiao H.H., Hung Y.H., Hsiao H.P., Tseng S.B., Tsai H.J., Liu Y.C., Liu T.C., Chao M.C., Chang Y., and Lin S.F. Case of chronic lymphocytic leukemia with unusual chromosome aberrations. Int J Hematol 80 (2004) 351-353
21. Merchant S., Schlette E., Sanger W., Lai R., and Medeiros L.J. Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc. Arch Pathol Lab Med 127 (2003) 305-309
22. Cuneo A, Castoldi GL, Burkitt's lymphoma (BL). In: Atlas of genetics and cytogenetics in oncology and haematology [Internet]. Updated March 2001. Available at: http://www.infobiogen.fr/services/chromcancer/Anomalies/BurkittID2077.html.
23. Zeidler R., Joos S., Delecluse H.J., Klobeck G., Vuillaume M., Lenoir G.M., Bornkamm G.W., and Lipp M. Breakpoints of Burkitt lymphoma t(8;22) translocations map within a distance of 300 kb downstream of MYC. Genes Chromosomes Cancer 9 (1994) 282-287
24. Hecht J.L., and Aster J.C. Molecular biology of Burkitt lymphoma. J Clin Oncol 18 (2000) 3707-3721
25. Wilda M., Busch K., Klose I., Keller T., Woessmann W., Kreuder J., Harbott J., and Borkhardt A. Level of MYC overexpression in pediatric Burkitt lymphoma is strongly dependent on genomic breakpoint location within the MYC locus. Genes Chromosomes Cancer 41 (2004) 178-182
26. De Jong D., Voetdijk B.M., Beverstock G.C., van Ommen G.J., Willemze R., and Kluin P.M. Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma. N Engl J Med 318 (1988) 1373-1378
27. Shachaf C.M., Kopelman A.M., Arvanitis C., Karlsson A., Beer S., Mandl S., Bachmann M.H., Borowsky A.D., Ruebner B., Cardiff R.D., Yang Q., Bishop J.M., Contag C.H., and Felsher D.W. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431 (2004) 1112-1117
28. Tsimberidou A.M., and Keating M.J. Richter syndrome. Cancer 103 2 (2005) 216-228
29. Arranz E., Martinez B., Richart A., Echezarreta G., Roman A., Rivas C., and Benitez J. Increased C-MYC oncogene copy number detected with combined modified comparative genomic hybridization and FISH analysis in a Richter syndrome case with complex karyotype. Cancer Genet Cytogenet 106 (1998) 80-83
30. Brennscheidt U., Eick D., Kunzmann R., Martens U., Kiehntopf M., Mertelsmann R., and Herrmann F. Burkitt-like mutations in the c-myc gene locus in prolymphocytic leukemia. Leukemia 8 (1994) 897-902
31. Raghoebier S., van Krieken J.H., Kluin-Nelemans J.C., Gillis A., van Ommen G.J., Ginsberg A.M., Raffeld M., and Kluin P.M. Oncogene rearrangements in chronic B-cell leukemia. Blood 77 (1991) 1560-1564
32. Rechavi G., Katzir N., Brok-Simoni F., Holtzman F., Mandel M., Gurfinkel N., Givol D., Ben-Bassat I., and Ramot B. A search for bcl1, bcl2, and c-myc oncogene rearrangements in chronic lymphocytic leukemia. Leukemia 3 (1989) 57-60
33. Catovsky D. Definition and diagnosis of sporadic and familial chronic lymphocytic leukemia. Hematol Oncol Clin North Am 18 (2004) 783-794 vii
34. Goldin L.R., Pfeiffer R.M., Li X., and Hemminki K. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood 104 6 (2004) 1850-1854